Establishing minimal clinically important differences for the Quality of Life Instrument of Chronic Gastritis QLICD-CG(V2.0) based on distribution-based methods
- PMID: 37173655
- PMCID: PMC10182708
- DOI: 10.1186/s12876-023-02777-5
Establishing minimal clinically important differences for the Quality of Life Instrument of Chronic Gastritis QLICD-CG(V2.0) based on distribution-based methods
Abstract
Background: To establish the lowest score reflecting meaningful changes from the perspective of patients is very important for explaining the results of patient reports. The measurement scale of quality of life in patients with chronic gastritis has been used in clinical practice, but the minimal clinically important difference (MCID) has not been worked out. In this paper, we use a distribution-based method to calculate the MCID of the scale QLICD-CG (Quality of Life Instruments for Chronic Diseases- Chronic Gastritis) (V2.0).
Methods: The QLICD-CG(V2.0) scale was used to evaluate the quality of life in patients with chronic gastritis. Since the methods for developing MCID were diverse and there was no uniform standard, we took MCID developed by anchor-based method as the gold standard, and compared the MCID of QLICD-CG(V2.0) scale developed by various distribution-based methods for selection. Standard deviation method (SD), effect size method (ES), standardized response mean method (SRM), standard error of measurement method (SEM) and reliable change index method (RCI) are given in the distribution-based methods.
Results: A total of 163 patients, with an average age of (52.37 ± 12.96) years old, were calculated according to the various methods and formulas given by the distribution-based method, and the results were compared with the gold standard. It was suggested that the results of the SEM method at the moderate effect (1.96) should be taken as the preferred MCID of the distribution-based method. And thus the MCID of the physical domain, psychological domain, social domain, general module, specific module and total score of the QLICD-CG(V2.0) scale were 9.29, 13.59, 9.27, 8.29, 13.49 and 7.86, respectively.
Conclusions: With anchor-based method as the gold standard, each method in distribution-based method has its own advantages and disadvantages. In this paper, 1.96SEM was found to have a good effect on the minimum clinically significant difference of the QLICD-CG(V2.0) scale, and it is recommended as the preferred method to establish MCID.
Keywords: Chronic gastritis; Distribution-based method; Minimal clinically important difference; Quality of life.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Development and validation of quality of life instruments for chronic diseases-Chronic gastritis version 2 (QLICD-CG V2.0).PLoS One. 2018 Nov 14;13(11):e0206280. doi: 10.1371/journal.pone.0206280. eCollection 2018. PLoS One. 2018. PMID: 30427879 Free PMC article.
-
Establishing minimal clinically important differences for the quality of life scale QLICD-SLE for patients with systemic lupus erythematosus based on ROC curve.Sci Rep. 2024 Sep 9;14(1):20982. doi: 10.1038/s41598-024-71116-9. Sci Rep. 2024. PMID: 39251635 Free PMC article.
-
Establishing Minimal Clinically Important Differences for the Quality of Life Instrument in Patients With Breast Cancer QLICP-BR (V2.0) Based on Anchor-Based and Distribution-Based Methods.Front Oncol. 2022 May 2;12:753729. doi: 10.3389/fonc.2022.753729. eCollection 2022. Front Oncol. 2022. PMID: 35586490 Free PMC article.
-
How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods.Health Qual Life Outcomes. 2020 May 12;18(1):136. doi: 10.1186/s12955-020-01344-w. Health Qual Life Outcomes. 2020. PMID: 32398083 Free PMC article.
-
Contemporary Analysis of Minimal Clinically Important Difference in the Neurosurgical Literature.Neurosurgery. 2021 Mar 15;88(4):713-719. doi: 10.1093/neuros/nyaa490. Neurosurgery. 2021. PMID: 33369670
Cited by
-
Air pollution and oesophageal cancer risk.Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):344. doi: 10.1038/s41575-023-00786-z. Nat Rev Gastroenterol Hepatol. 2023. PMID: 37085615 No abstract available.
-
Baduanjin exercise combined with moxibustion box for gastrointestinal dysfunction in the elderly: a protocol of prospective, randomized controlled trial.Front Med (Lausanne). 2025 Jul 28;12:1620346. doi: 10.3389/fmed.2025.1620346. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40792300 Free PMC article.
References
-
- Zhang H, Wang F, Jiang D. Quality of life and its influencing factors in patients with chronic gastritis. Chin Health Eng. 2022;21(01):101–103.
-
- WHO. The development of the WHO quality of life assessment intrument. Geneva: WHO; 1993. p. 1.
-
- Bungay KM, Bayer JG. Principals of Pharmacoeconomics:health related quality of life, an overview[M] Cincinnati: Harvey Whitney Books Company; 1996. pp. 129–147.
-
- Balestroni G, Bertolotti G. L'EuroQol-5D (EQ-5D): uno strumento per la misura della qualità della vita [EuroQol-5D (EQ-5D): an instrument for measuring quality of life] Monaldi Arch Chest Dis. 2012;78(3):155–159. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources